Associated Papers
Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.
Kitakaze K et al.
The Journal of Clinical Investigation, 2016
Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.
Matsuoka K et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy, 2011
Select a paper to view details